[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.241.199. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 24, 1999

Use of Antiretroviral Therapy by Intravenous Drug Users With HIV

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(8):699-701. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-8-jbk0224

To the Editor: Dr Celentano et al1 reported that current IDUs and those recently incarcerated were less likely to receive protease inhibitors (PIs), but patients with acquired immunodeficiency syndrome (AIDS) were more likely to receive PIs. We conducted a study to determine characteristics associated with failure to receive PIs and found similar results.

First Page Preview View Large
First page PDF preview
First page PDF preview
×